237
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Computational approach identifies protein off-targets for Isoniazid-NAD adduct: hypothesizing a possible drug resistance mechanism in Mycobacterium tuberculosis

, , , , , & show all
Pages 1697-1710 | Received 07 Mar 2019, Accepted 29 Apr 2019, Published online: 16 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Adeniyi T. Adewumi, Ahmed Elrashedy, Opeyemi S. Soremekun, Mary B. Ajadi & Mahmoud E. S. Soliman. (2022) Weak spots inhibition in the Mycobacterium tuberculosis antigen 85C target for antitubercular drug design through selective irreversible covalent inhibitor-SER124. Journal of Biomolecular Structure and Dynamics 40:7, pages 2934-2954.
Read now
Jian-hua Zhou, Hua Li, Xuerui Li, Jing Gao, Long- Xu, Shengyi Han, Yongsheng Liu, Youjun Shang & Xiaoan Cao. (2021) Tracing Brucella evolutionary dynamics in expanding host ranges through nucleotide, codon and amino acid usages in genomes. Journal of Biomolecular Structure and Dynamics 39:11, pages 3986-3995.
Read now
Muhammad Tahir Khan & Shaukat Iqbal Malik. (2020) Structural dynamics behind variants in pyrazinamidase and pyrazinamide resistance. Journal of Biomolecular Structure and Dynamics 38:10, pages 3003-3017.
Read now

Articles from other publishers (1)

Syed Aun Muhammad, Hiba Ashfaq, Sidra Zafar, Fahad Munir, Muhammad Babar Jamshed, Jake Chen & Qiyu Zhang. (2020) Polyvalent therapeutic vaccine for type 2 diabetes mellitus: Immunoinformatics approach to study co-stimulation of cytokines and GLUT1 receptors. BMC Molecular and Cell Biology 21:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.